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Reperfusion injury can occur when blood flow is restored after a transient period of ischaemia. The resulting cascade of
reactive oxygen species damages tissue. This mechanism may contribute to the tissue damage produced by 5-aminolaevulinic
acid-induced photodynamic therapy, if this treatment temporarily depletes oxygen in an area that is subsequently
reoxygenated. This was investigated in the normal colon of female Wistar rats. All animals received 200 mg kg71 5-
aminolaevulinic acid intravenously 2 h prior to 25 J (100 mW) of 628 nm light, which was delivered continuously or
fractionated (5 J/150 second dark interval/20 J). Animals were recovered following surgery, killed 3 days later and the
photodynamic therapy lesion measured macroscopically. The effects of reperfusion injury were removed from the experiments
either through the administration of free radical scavengers (superoxide dismutase (10 mg kg71) and catalase (7.5 mg kg71)
in combination) or allopurinol (an inhibitor of xanthine oxidase (50 mg kg71)). Prior administration of the free radical
scavengers and allopurinol abolished the macroscopic damage produced by 5-aminolaevulinic acid photodynamic therapy in
this model, regardless of the light regime employed. As the specific inhibitor of xanthine oxidase (allopurinol) protected against
photodynamic therapy damage, it is concluded that reperfusion injury is involved in the mechanism of photodynamic therapy
in the rat colon.
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Photodynamic Therapy (PDT) is a non-thermal technique, which
can produce localised tissue necrosis, for the treatment of tumours
and pre-malignant conditions in a range of organs. There is parti-
cular interest for treating pulmonary, gastrointestinal, skin and
brain tumours as well as superficial bladder cancer (Stewart et al,
1998). PDT requires the systemic or topical administration of a
photosensitiser, which is activated in situ by light of a specific
wavelength to form cytotoxic species in the presence of molecular
oxygen (Henderson and Dougherty, 1992).
PDT with the exogenous administration of 5-aminolaevulinic
acid (ALA) is currently of interest, particularly for the treatment
of superficial cutaneous tumours (Peng et al, 1997a). This
compound enters the normal mammalian, tetrapyrrole biosynthetic
pathway and is converted into a natural photosensitiser, protopor-
phyrin IX (PPIX) (Kennedy and Pottier, 1992). However, the effect
produced by ALA-PDT is usually superficial, which often limits its
clinical value (Regula et al, 1995; Barr et al, 1996). Experimentally,
several techniques have been shown to enhance ALA-PDT. These
include using a low light fluence rate (Robinson et al, 1998),
ALA esters (Peng et al, 1996), iron chelators (Ortel et al, 1993;
Curnow et al, 1998) and light dose fractionation (Messmann et
al, 1995). In our studies, temporarily interrupting the light admin-
istration for 150 s increased the area of tissue necrosis by a factor
of 3 (Curnow et al, 1999). The precise mechanism of this is not
fully understood. It may be due to reoxygenation (Curnow et al,
2000) or relocalisation of the photosensitiser (Anholt and Moan,
1991) during the dark interval, but another possibility is reperfu-
sion injury.
Reperfusion injury can occur as the blood supply is restored
after a transient period of ischaemia. This happens as the enzyme,
xanthine oxidase, becomes activated in a poorly oxygenated envir-
onment. Concomitantly, ATP is broken down, producing the
purine substrates necessary for this enzyme to produce superoxide
when oxygen is reintroduced (McCord, 1987). A schematic
summary of this process is shown in Figure 1. If reversible vaso-
constriction occurs during the first fraction of a fractionated
PDT treatment, this would result in an oxygen and thus energy
compromised environment, making it conceivable that free radical
damage could occur in this manner when the tissue is reperfused
during the dark interval.
Superoxide is produced in most, if not all aerobic cells and the
enzyme superoxide dismutase (SOD) is present intracellularly to
remove it. Dismutation of superoxide produces hydrogen peroxide
and the enzymes catalase (CAT) and glutathione peroxidase exist to
remove this compound. Together, these enzymes protect cells
against the reduced oxygen intermediates produced during normal
aerobic metabolism. When superoxide and hydrogen peroxide
production is excessive, however, such as following reperfusion
injury, the protective enzymes are unable to cope, thus resulting
in cell damage. Some of this damage may be mediated by the tran-
sition metal, iron, which can convert superoxide and hydrogen
peroxide into aggressive oxidants such as the hydroxyl radical
(by Haber-Weiss and Fenton-type reactions), which can then
damage DNA, proteins and lipids, resulting in cell death. It is also
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possible that hydroxyl radicals can be produced (in a reaction inde-
pendent of metal ions) from peroxynitrite (which itself can damage
the cell membrane). Peroxynitrite can be produced from superox-
ide and nitric oxygen (which can also be toxic to cells) both of
which can be increased when ischaemic tissues are reperfused
(Gutteridge and Halliwell, 1990). The ultimate destructive effect
of these reactive species is amplified many times by the cascade
of free radical production they generate. Figure 2 summarises some
of these reactions, which are possible following reperfusion injury.
If SOD and CAT are present together in large quantities prior to
ischaemia or at the start of reperfusion (through exogenous admin-
istration), they can produce significant protection against
reperfusion injury (Gross et al, 1986; Jolly et al, 1984; Mittal et
al, 1988). Allopurinol is a potent and highly specific inhibitor of
the conversion of xanthine dehydrogenase to xanthine oxidase
and can also be used to prevent reperfusion injury (Crowell et
al, 1969; Paller et al, 1984).
This study investigates the contribution of reperfusion injury to
the damage produced by continuous and fractionated PDT light
regimes through the administration of free radical scavengers (SOD
and CAT) and an enzyme inhibitor (allopurinol) to prevent any
tissue damage caused by this mechanism. PDT is being developed
for cancer therapy, but most of the studies designed to elucidate its
mechanism of action and enhance the effect have been undertaken
on normal tissues (Messmann et al, 1995) as experimental conditions
are so much easier to control than in malignant tissue. This approach
has led to many of the most important advances in establishing when
it is safe and appropriate to use PDT in the treatment of human
cancers (Bown, 1990). Reperfusion injury has not been studied
previously in relation to PDT and although the response of normal
and tumour tissue to PDT related reperfusion injury may not be
exactly the same, it would be inappropriate to try and understand
it in tumour tissue until the basic principles had been studied in
normal tissue. For these reasons, these experiments were undertaken
on normal rat colon, a model on which we have carried out much
basic work on PDT over a period of many years.
MATERIALS AND METHODS
Chemicals
ALA powder (DUSA Pharmaceuticals, USA) was dissolved in
physiological strength phosphate buffered saline (PBS) and given
intravenously at a concentration of 200 mg ml71 and a maximum
volume of 0.2 ml. Superoxide dismutase and catalase (Sigma-
Aldrich Co. Ltd., Poole, UK) were dissolved together in PBS and
were administered intravenously at a concentration of 23.3 and
10 KU ml71 respectively, maximum volume 0.2 ml. Allopurinol
(Sigma-Aldrich Co. Ltd., Poole, UK) was dissolved in PBS and
administered intravenously at a concentration of 50 mg ml71
and a maximum volume of 0.2 ml.
Animal model
Normal, female, Wistar rats (120 – 200 g) were used throughout
and all procedures were conducted under licences granted by the
UK Home Office in accordance with their regulations and the
UKCCCR Guidelines (UKCCCR, 1998). The animals were anaes-
thetised for all parts of the procedure using inhaled halothane
and analgesia was administered subcutaneously following surgery
(buprenorphine hydrochloride).
PDT studies
All animals were given 200 mg kg71 ALA intravenously, 2 h prior
to surgery. The colon was accessed for PDT via a laparotomy. The
light source used was a 628 nm diode laser (Diomed Ltd.,
Cambridge, UK). A total energy of 25 J was delivered via a
200 mm plane cleaved optical fibre passed through the anti-mesen-
teric colon wall (approximately 1 cm distal to the caecum) so that
it just touched the mucosa of the opposite side (area of
contact=0.03 mm2). The power output of the optical fibre was kept
at 100 mW. The rest of the abdominal viscera were shielded from
forward light scatter by a piece of opaque paper positioned so that
it did not touch the colon or affect its light distribution. This is a
model that we have used many times in the past (Messmann et al,
1995). The light fluence rate where the fibre touches the tissue is
high (320 W cm2) but no thermal effect was observed macroscopi-
cally in the light only control group at 3 days. As the light fluence
rate falls rapidly with increasing distance along the colon wall from
the fibre tip, measuring the area of the zone of necrosis in the wall
of the colon is a convenient way of comparing the efficacy of PDT
with different treatment parameters. The light dose was either
delivered continuously or fractionated by a single interval of
150 s after one fifth of the energy dose had been delivered.
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Figure 1 Schematic representation of the proposed mechanism for the
ischaemia-induced production of reactive oxygen species as adapted from
McCord (1985) with the kind permission of The New England Journal of
Medicine.
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Figure 2 Summary of some of the reactions possible following reperfu-
sion injury as adapted from Hammond et al (1985) with the kind permis-
sion of The Canadian Journal of Physiology and Pharmacology.
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The inhibitory compounds (10 mg kg71 SOD and 7.5 mg kg71
CAT or 50 mg kg71 allopurinol) were given intravenously either
just before or immediately after illumination, the dosage and
timing being chosen to mimic those of previous studies, where
these compounds had been used successfully to prevent reperfusion
injury (Crowell et al, 1969; Jolly et al, 1984; Paller et al, 1984; Gross
et al, 1986; Mittal et al, 1988). Due to the short half-life of SOD in
blood (6 min), the combination of SOD and CAT was adminis-
tered as close to the beginning of the irradiation period as
possible (Gross et al, 1986) whereas allopurinol was given 15 min
prior to illumination. Animals were treated in groups of three with
each type of inhibitory compound. Control groups (drug only,
light only or both) received no radical scavengers or enzyme inhi-
bitors. Animals were killed 3 days after light delivery and at post
mortem, the area of PDT necrosis produced in the colon was
determined macroscopically using an image analysis system. Some
sections were examined histologically to confirm the macroscopic
findings.
Statistical analysis of the area of necrosis between each treatment
group and the appropriate control group was conducted using
unpaired Student t-tests.
RESULTS
At post mortem, the lesions seen in the colon were approximately
elliptical when the colon was opened and laid flat. Histological analy-
sis on representative specimens showed necrosis of the same extent as
that measured macroscopically on the mucosa surface. The area of
necrosis (mm2) produced by each of the treatment regimes is shown
in Table 1. There was no effect in animals receiving either drug alone
or light alone. Control groups receiving PDT (drug and light) but no
scavengers or enzyme inhibitors produced areas of necrosis, with the
fractionated group producing approximately three times the area of
necrosis seen after continuous illumination. This finding is consistent
with our previous work (Curnow et al, 1999), although the absolute
areas were smaller than in the previous publication as it was necessary
to use a 628 nm laser rather than the optimum wavelength of
635 nm. Use of the scavengers and enzyme inhibitor prior to irradia-
tion completely inhibited the PDT effect. When these agents were
given after illumination, the PDT effect was drastically reduced,
although not completely eliminated.
DISCUSSION
This study has shown that the administration of either the scaven-
ging enzymes, SOD and CAT, or the xanthine oxidase inhibitor,
allopurinol, prior to illumination, can prevent ALA-PDT from
producing damage in the normal rat colon, whether the light dose
is fractionated or continuous.
SOD and CAT remove harmful superoxide and hydrogen perox-
ide. These are known to be produced during reperfusion injury,
but the effect is not specific. It is conceivable that cellular damage
via singlet oxygen production would trigger a similar cascade of
oxygen free radicals and reduced oxygen intermediates, particularly
as the mitochondrion is reported to be a major site of ALA-PDT
induced damage (Peng et al, 1997b). This would uncouple the elec-
tron transport chain ‘leaking’ further electrons to oxygen to form
these reactive oxygen species. The disruption of cellular membranes
has also been reported and once lysis of cellular compartments has
been induced, the resultant free radical cascade would be cataclys-
mic for the cell.
The experiments with allopurinol are different. Allopurinol is
known to be a specific inhibitor of the conversion of xanthine
dehydrogenase into xanthine oxidase, which results in allopurinol
being a specific inhibitor of reperfusion injury. The pre-administra-
tion of this compound would not be expected to have any effect on
the production of reactive oxygen species or free radicals by any
mechanism other than reperfusion injury. As the presence of this
compound prior to light irradiation prevented the necrosis
normally produced by ALA-PDT, it can be concluded that reperfu-
sion injury must be playing some role in producing the necrosis in
this animal model. It is known that if a tissue is not perfused, even
for a period of time as short as 10 s (Roy and McCord, 1983), it is
possible for xanthine dehydrogenase to be converted into xanthine
oxidase. From previous studies monitoring oxygen levels during
similar continuous and fractionated ALA-PDT treatments (Curnow
et al, 2000), the tissue oxygen level can fall to zero at sites that
subsequently become necrotic, even though there may be some
temporary recovery of oxygen levels shortly after completion of
illumination. This reoxygenation, which occurs shortly after the
irradiation period finishes, may explain why the inhibitory
compounds in the present study were not so effective when admi-
nistered just after light irradiation rather than prior to
illumination. Some re-oxygenation after light delivery would, of
course, be essential for reperfusion injury to play a part in any
PDT, with or without fractionation.
Our results suggest that reperfusion injury may play a part in
producing PDT necrosis, at least with ALA. It could also explain
the increased area of necrosis produced by fractionating the light
as a result of reperfusion injury following reversal of temporary
ischaemia in the treated area after the first light fraction as well
as after completion of the final light fraction.
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Table 1 Mean area of necrosis (mm2) as a function of treatment regime. 200 mg kg71 ALA i.v. was administered 2 h prior to 25 J of 628 nm light
(100 mW) using a diode laser. The energy dose was either continuous (C) or fractionated (F). Fractionated groups were interrupted by one interval of
150 s after one fifth of the light dose had been delivered whereas the continuous groups were not interrupted at all. The SOD+CAT or Allopurinol were
administered intravenously either prior to or immediately following illumination
Controls SOD+CAT Allopurinol SOD+CAT Allopurinol
Drug regime (no inhibitors) (pre-PDT) (pre-PDT) (post-PDT) (post-PDT)
Light regime C F C F C F C F C F
Area of necrosis in each animal 5 53 0 0 0 0 7 3 1 0
(mm2) 27 52 0 0 0 0 2 0 0 14
6 30 0 0 0 0 0 9 5 4
22
5
13
6
22
Mean area of necrosis (mm2) 13 45 0 0 0 0 3 4 2 6
n= 8 3 3 3 3 3 3 3 3 3
P5 – 0.001 0.038 0.004 0.038 0.004 0.099 0.007 0.072 0.011
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